No Data
No Data
No Data
No Data
No Data
Express News | Corcept Therapeutics Inc - Targets Year-End for Catalyst Treatment Data Release
ReutersApr 29 08:04 ET
Express News | Corcept Completes Enrollment in Phase 4 Catalyst Trial
ReutersApr 29 08:00 ET
Those Who Invested in Corcept Therapeutics (NASDAQ:CORT) Five Years Ago Are up 82%
When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking involves risks (and requires diversification) it can also provide excess returns.
Simply Wall StApr 25 06:11 ET
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update
GlobeNewswireApr 24 16:05 ET
Express News | HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $38 Price Target
Moomoo 24/7Apr 23 13:28 ET
Corcept Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/23/2024 58.33% HC Wainwright & Co. → $38 Reiterates Buy → Buy 02/16/2024 75% Truist Securities $36 → $4
BenzingaApr 23 13:27 ET
No Data
No Data